Tamarack Advisers, LP Rigel Pharmaceuticals Inc Transaction History

Tamarack Advisers, LP

$2.12 Billion
Q4 2023

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$1.12 - $1.82 $840,000 - $1.37 Million	-750,000 Reduced 37.5%	1,250,000 $1.61 Million
Q1 2023 May 10, 2023	SELL	$1.25 - $2.0 $375,000 - $600,000	-300,000 Reduced 13.04%	2,000,000 $2.64 Million
Q4 2022 Feb 10, 2023	BUY	$0.67 - $11.9 $201,000 - $3.57 Million	300,000 Added 15.0%	2,300,000 $3.45 Million
Q2 2022 Aug 16, 2022	SELL	$0.67 - $3.19 $837,500 - $3.99 Million	-1,250,000 Reduced 38.46%	2,000,000 $2.26 Million
Q1 2022 May 11, 2022	SELL	$2.22 - $3.45 $2.78 Million - $4.31 Million	-1,250,000 Reduced 27.78%	3,250,000 $9.72 Million
Q4 2021 Feb 14, 2022	SELL	$2.36 - $3.57 $5.9 Million - $8.93 Million	-2,500,000 Reduced 35.71%	4,500,000 $11.9 Million
Q3 2021 Nov 12, 2021	BUY	$3.5 - $4.5 $2.1 Million - $2.7 Million	600,000 Added 9.38%	7,000,000 $25.4 Million
Q2 2021 Aug 13, 2021	SELL	$3.09 - $4.54 $6.03 Million - $8.85 Million	-1,950,000 Reduced 23.35%	6,400,000 $27.8 Million
Q1 2021 May 12, 2021	BUY	$3.35 - $4.93 $3.02 Million - $4.44 Million	900,000 Added 12.08%	8,350,000 $28.6 Million
Q4 2020 Feb 10, 2021	SELL	$2.35 - $3.74 $117,500 - $187,000	-50,000 Reduced 0.67%	7,450,000 $26 Million
Q3 2020 Nov 12, 2020	BUY	$1.78 - $4.13 $1.16 Million - $2.68 Million	650,000 Added 9.49%	7,500,000 $18 Million
Q2 2020 Aug 11, 2020	BUY	$1.41 - $2.05 $1.83 Million - $2.67 Million	1,300,000 Added 23.42%	6,850,000 $12.5 Million
Q1 2020 May 14, 2020	SELL	$1.27 - $3.0 $254,000 - $600,000	-200,000 Reduced 3.48%	5,550,000 $8.66 Million
Q4 2019 Feb 11, 2020	BUY	$1.6 - $2.43 $440,000 - $668,250	275,000 Added 5.02%	5,750,000 $11.8 Million
Q2 2019 Aug 12, 2019	BUY	$2.02 - $2.61 $353,500 - $456,750	175,000 Added 3.3%	5,475,000 $14 Million
Q1 2019 May 13, 2019	SELL	$2.0 - $2.65 $400,000 - $530,000	-200,000 Reduced 3.64%	5,300,000 $13.6 Million
Q4 2018 Feb 11, 2019	BUY	$2.08 - $3.36 $1.98 Million - $3.19 Million	950,000 Added 20.88%	5,500,000 $12.7 Million
Q3 2018 Nov 13, 2018	BUY	$2.6 - $3.59 $5.01 Million - $6.91 Million	1,925,000 Added 73.33%	4,550,000 $14.6 Million
Q2 2018 Aug 14, 2018	BUY	$2.83 - $4.11 $7.43 Million - $10.8 Million	2,625,000 New	2,625,000 $7.43 Million

Others Institutions Holding RIGL

# of Institutions

Shares Held

334K

Call Options Held

Put Options Held

View Full List

About RIGEL PHARMACEUTICALS INC

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.96B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

More about RIGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tamarack Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Tamarack Advisers, LP with notifications on news.

Account